Legros, Laurence http://orcid.org/0000-0002-9567-7879
Pascale, Alina http://orcid.org/0000-0001-9511-3726
Guettier, Catherine http://orcid.org/0000-0003-0791-5505
Eftekhari, Pirayeh
Merabet, Yasmina Ben
Stang, Maryse
Bossevot, Rachel http://orcid.org/0000-0002-6646-2481
Goldschmidt, Emma http://orcid.org/0000-0002-2153-5384
Ulusakarya, Ayhan http://orcid.org/0000-0001-8683-6818
Morisset, Stephane http://orcid.org/0000-0002-7747-113X
Lewin, Maïté http://orcid.org/0000-0002-9450-8096
Samuel, Didier http://orcid.org/0000-0001-9481-3616
Rosmorduc, Olivier http://orcid.org/0000-0002-6695-3088
Article History
Received: 2 December 2022
Accepted: 3 March 2023
First Online: 24 March 2023
Declarations
:
: LL reports personal fees from Bristol Myers-Squibb (BMS), Incyte, Novartis, and Pfizer and research support from Incyte outside of the submitted work. OR reports participation on data safety monitoring boards or advisory boards for Bayer, Eisai, and Sitrex.